Yixintang Pharmaceutical (Sichuan) Co., Ltd. announced a private placement of common shares for gross proceeds of CNY 250,000,000 from returning investor Yixintang Pharmaceutical Group Co., Ltd. to retain its 100% stake in the company, on July 9, 2021. On post completion, the registered capital of company will be increased from CNY 50,000,000 to CNY 300,000,000. The transaction has been approved by the board of directors of the investor at the 6th Extraordinary Meeting of the 5th directorate and is subject to approval from shareholders.